[1]王文学,唐宝莉,李小雪.加味麻杏石甘汤治疗痰热郁肺型小儿肺炎157例[J].西部中医药,2019,32(08):82-84.
　WANG Wenxue,TANG Baoli,LI Xiaoxue.Treating 157 Cases of Infantile Pneumonia of Phlegm-heat Stagnating Lung Pattern with Modified Maxing Shigan Decoction[J].Western Journal of Traditional Chinese Medicine,2019,32(08):82-84.
点击复制

加味麻杏石甘汤治疗痰热郁肺型小儿肺炎157例
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年08期
页码:
82-84
栏目:
出版日期:
2019-08-15

文章信息/Info

Title:
Treating 157 Cases of Infantile Pneumonia of Phlegm-heat Stagnating Lung Pattern with Modified Maxing Shigan Decoction
文章编号:
1004-6852(2019)08-0082-03
作者:
王文学，唐宝莉，李小雪
扶风县中医医院，陕西 扶风 722200
Author(s):
WANG Wenxue, TANG Baoli, LI Xiaoxue
Fufeng County TCM Hospital, Fufeng 722200, China
关键词:
肺炎; 痰热郁肺证; 小儿; 加味麻杏石甘汤; 炎症因子
Keywords:
pneumonia;  phlegm-heat stagnating lung pattern;  infantile;  modified Maxing Shigan decoction; inflammatory factor
分类号:
R563.1
文献标志码:
B
摘要:
目的：观察加味麻杏石甘汤治疗痰热郁肺型小儿肺炎的临床疗效。方法：将257例患儿根据治疗方法的不同分为观察组157例与对照组100例，对照组给予常规西医治疗，观察组在对照组治疗的基础上给予加味麻杏石甘汤治疗，2组均治疗7天。观察2组治疗前后临床疗效，不良反应发生率，临床恢复情况及血清炎症因子水平。结果：总有效率观察组为95.5%，对照组为79.0%，2组比较差异有统计学意义(P＜0.05)。不良反应发生率观察组为2.5%，对照组为15.0%，2组比较差异有统计学意义(P＜0.05)。肺部啰音消失时间、止咳时间、退热时间、住院时间2组比较，差异有统计学意义(P＜0.05)。血清白细胞介素3(IL-3)及C反应蛋白(CRP)水平治疗前后2组组内比较，差异有统计学意义(P＜0.05)；治疗后组间比较差异也有统计学意义(P＜0.05)。结论：加味麻杏石甘汤治疗痰热郁肺型小儿肺炎能有效缓解临床症状，提高治疗效果，减少不良反应的发生，其作用机制可能与减少炎症因子IL-3与CRP的释放有关。
Abstract:
Objective: To observe curative effects of modified Maxing Shigan decoction in the treatment for infantile pneumonia of phlegm-heat stagnating lung pattern. Methods: All 257 children were allocated to 157 cases of the observation group and 100 cases of the control group according to different therapeutic methods, the control group accepted conventional Western medicine, and the observation group were treated with modified Maxing Shigan decoction based on conventional Western medicine, both groups were treated for seven days. To observe curative effects, the incidence of adverse reaction, clinical recovery conditions and the levels of serum inflammatory factors before and after treating between both groups. Results: Total effective rate of the observation group was 95.5%, higher than 79.0% of the control group, and the difference had statistical meaning (P＜0.05). The incidence of adverse reaction of the observation group was 2.5%, lower than 15.0% of the control group, and the difference presented statistical meaning (P＜0.05). The difference could be found in the disappearing time of pulmonary rale, the time of stopping cough, the time of abating fever and hospitalization time between both groups (P＜0.05). The difference is statistically significant in the levels of IL-3 and CRP within two groups before and after treating (P＜0.05); the difference could be found between both groups after treating (P＜0.05). Conclusion: Modified Maxing Shigan decoction could relieve clinical symptoms, raise therapeutic effects, reduce the incidence of adverse reaction in the treatment for infantile pneumonia of phlegm-heat stagnating lung pattern, and its mechanism might be related to the release of IL-3 and CRP.

相似文献/References:

[1]燕忠生,魏千程,李俊,等.三种不同功效中药注射制剂治疗放射性肺炎的实验研究[J].西部中医药,2014,27(03):36.
　YAN Zhongsheng,WEI Qiancheng,LI Jun,et al.Experimental Study on Treating Radiation Pneumonitis by Three Kinds of Different Herbal Injections[J].Western Journal of Traditional Chinese Medicine,2014,27(08):36.
[2]李丹,姚丹△.酚妥拉明联合肺部中频理疗在治疗小儿肺炎中的应用[J].西部中医药,2017,30(12):80.
　LI Dan,YAO Dan.Application of Phentolamine Combined with Pulmonary Intermediate Frequency Physiotherapy to the Treatment for Infantile Pneumonia[J].Western Journal of Traditional Chinese Medicine,2017,30(08):80.
[3]王 雷,李盛华,周明旺.新型冠状病毒肺炎疫情下骨伤科疾病的诊疗思考[J].西部中医药,2020,33(S1):11.
　Under the Impact of COVID-9 Epidemic.Reflection on the Diagnosis and Treatment of Orthopedic Diseases[J].Western Journal of Traditional Chinese Medicine,2020,33(08):11.
[4]桑天庆,周红光△.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2020,33(S1):18.
　SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(08):18.
[5]王雷,李盛华,周明旺.新型冠状病毒肺炎疫情下骨伤科疾病的诊疗思考[J].西部中医药,2020,33(03):5.[doi:10.12174/j.issn.1004-6852.2020.03.02]
　WANG Lei,LI Shenghua,ZHOU Mingwang.Reflection on the Diagnosis and Treatment of Orthopedic Diseases Under the Impact of COVID-19 Epidemic[J].Western Journal of Traditional Chinese Medicine,2020,33(08):5.[doi:10.12174/j.issn.1004-6852.2020.03.02]
[6]杨晓慧,何菊邻.中医药治疗小儿肺炎的知识图谱分析[J].西部中医药,2020,33(03):73.[doi:10.12174/j.issn.1004-6852.2020.03.20]
　YANG Xiaohui,HE Julin.Knowledge Map Analysis of TCM in Treating Infantile Pneumonia[J].Western Journal of Traditional Chinese Medicine,2020,33(08):73.[doi:10.12174/j.issn.1004-6852.2020.03.20]
[7]时佳,叶晨,杨宗国,等.非危重型新型冠状病毒肺炎97例临床观察[J].西部中医药,2022,35(03):5.[doi:10.12174/j.issn.2096-9600.2022.03.02]
　SHI Jia,YE Chen,YANG Zongguo,et al.Clinical Observation on 97 Patients with Non-critical Type COVID-19[J].Western Journal of Traditional Chinese Medicine,2022,35(08):5.[doi:10.12174/j.issn.2096-9600.2022.03.02]
[8]魏建功.桑苏止咳汤治疗痰热郁肺型急性支气管炎75例[J].西部中医药,2020,33(08):83.[doi:10.12174/j.issn.1004-6852.2020.08.21]
　WEI Jiangong.Sangsu Zhike Decoction in Treating 75 Cases of Acute Bronchitis of Phlegm-heat Stagnating Lung Pattern[J].Western Journal of Traditional Chinese Medicine,2020,33(08):83.[doi:10.12174/j.issn.1004-6852.2020.08.21]
[9]桑天庆,周红光.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2021,34(02):6.[doi:10.12174/j.issn.2096-9600.2021.02.02]
　SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2021,34(08):6.[doi:10.12174/j.issn.2096-9600.2021.02.02]
[10]马思遥,任延毅,王雪冰,等.养阴活血类中药复方治疗放射性肺炎的Meta分析[J].西部中医药,2023,36(01):70.[doi:10.12174/j.issn.2096-9600.2023.01.17]
　MA Siyao,REN Yanyi,WANG Xuebing,et al.Meta-analysis of Compound Traditional Chinese Medicine of Nourishing-Yin and Promoting Blood Circulation in the Treatment of Radioactive Pneumonia[J].Western Journal of Traditional Chinese Medicine,2023,36(08):70.[doi:10.12174/j.issn.2096-9600.2023.01.17]

备注/Memo

备注/Memo:
收稿日期：2018-09-08作者简介：王文学(1977—)，男，副主任医师。研究方向：儿科疾病的中医诊治。
更新日期/Last Update: 2019-08-15